Journal article icon

Journal article

Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease

Abstract:
Epigenetic alterations may provide important insights into gene-environment interaction in inflammatory bowel disease (IBD). Here we observe epigenome-wide DNA methylation differences in 240 newly-diagnosed IBD cases and 190 controls. These include 439 differentially methylated positions (DMPs) and 5 differentially methylated regions (DMRs), which we study in detail using whole genome bisulphite sequencing. We replicate the top DMP (RPS6KA2) and DMRs (VMP1, ITGB2 and TXK) in an independent cohort. Using paired genetic and epigenetic data, we delineate methylation quantitative trait loci; VMP1/microRNA-21 methylation associates with two polymorphisms in linkage disequilibrium with a known IBD susceptibility variant. Separated cell data shows that IBD-associated hypermethylation within the TXK promoter region negatively correlates with gene expression in whole-blood and CD8+T cells, but not other cell types. Thus, site-specific DNA methylation changes in IBD relate to underlying genotype and associate with cell-specific alteration in gene expression.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1038/ncomms13507

Authors


More by this author
Role:
Author
ORCID:
0000-0002-9550-0897


More from this funder
Funding agency for:
Kennedy, NA
Grant:
WT097943MA


Publisher:
Nature Publishing Group
Journal:
Nature Communications More from this journal
Volume:
7
Article number:
13507
Publication date:
2016-11-25
Acceptance date:
2016-10-11
DOI:
ISSN:
2041-1723


Pubs id:
pubs:688060
UUID:
uuid:7022ab37-9bf3-475d-b12b-c96588368ce6
Local pid:
pubs:688060
Source identifiers:
688060
Deposit date:
2018-08-10

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP